Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis

被引:1
|
作者
Asif, Talal [1 ,2 ]
Vij, Aviral [2 ,3 ]
Radzik, Bartlomiej [4 ]
Stern, Hudson [5 ]
Simples, Patricia [4 ]
Ghadiali, Quraish [5 ]
Malhotra, Saurabh [2 ,3 ]
机构
[1] Univ Missouri, Truman Med Ctr, Div Cardiol, Kansas City, KS USA
[2] Cook Cty Hlth, Div Cardiol, Chicago, IL 60651 USA
[3] Rush Med Coll, Div Cardiol, Chicago, IL 60612 USA
[4] Cook Cty Hlth, Div Pathol, Chicago, IL USA
[5] Cook Cty Hlth, Div Ophthalmol, Chicago, IL USA
关键词
Hereditary transthyretin cardiac amyloidosis; Pyrophosphate scintigraphy; Cardiac magnetic resonance;
D O I
10.1007/s12350-021-02865-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a case of a patient with worsening visual acuity and dense vitreal debris who was found to have vitreal transthyretin amyloid (ATTR) infiltration. Cardiac workup, performed to identify systemic amyloidosis, demonstrated focal myocardial amyloid infiltration on pyrophosphate (PYP) scintigraphy and cardiac magnetic resonance (CMR), resulting in a diagnosis of subclinical ATTR cardiac amyloidosis (ATTR-CA). Patient was identified as a carrier of p.S70R mutation which results in an aggressive ATTR phenotype. Patient is tolerating transthyretin silencer therapy well. Through this case, we discuss the role of a multimodality imaging approach for the diagnosis of subclinical ATTR-CA.
引用
收藏
页码:792 / 799
页数:8
相关论文
共 50 条
  • [31] Performance of 99mTc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis
    Honghui Guo
    Sha Wu
    Xin Xiang
    Shuai Wang
    Zhihui Fang
    Qianchun Ye
    Yao Zou
    Yunhua Wang
    Daoquan Peng
    Xiaowei Ma
    [J]. Annals of Nuclear Medicine, 2024, 38 : 288 - 295
  • [32] Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis
    Gisela D. Puig-Carrion
    Alex Reyentovich
    Stuart D. Katz
    [J]. Clinical Autonomic Research, 2019, 29 : 45 - 53
  • [33] FROM BOWEL ULTRASOUND TO A DIAGNOSIS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS
    Toppeta, A.
    Dell'Era, A.
    Mantia, B.
    Molteni, P.
    Pellegrinelli, A.
    Marceca, A.
    Ardizzone, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 : S176 - S177
  • [34] Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis
    Puig-Carrion, Gisela D.
    Reyentovich, Alex
    Katz, Stuart D.
    [J]. CLINICAL AUTONOMIC RESEARCH, 2019, 29 (Suppl 1) : 45 - 53
  • [35] Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis
    Carroll, Antonia
    Dyck, P. James
    de Carvalho, Mamede
    Kennerson, Marina
    Reilly, Mary M.
    Kiernan, Matthew C.
    Vucic, Steve
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022,
  • [36] Hereditary transthyretin amyloidosis
    Hund, E.
    [J]. NERVENARZT, 2014, 85 (10): : 1291 - 1297
  • [37] Prognostic impact of diagnosis of transthyretin cardiac amyloidosis
    Arana, X.
    Goena, C.
    Villanueva, I.
    Solla, I.
    Rengel, A.
    Manas, L.
    Rilo, I.
    Gomez, A.
    Querejeta, R.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 71 - 71
  • [38] Are there predictor variables for the diagnosis of transthyretin cardiac amyloidosis?
    Goena, C.
    Arana, X.
    Villanueva, I.
    Solla, I.
    Rengel, A.
    Querejeta, R.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 859 - 859
  • [39] Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
    Yamamoto, Hiroyuki
    Yokochi, Tomoki
    [J]. ESC HEART FAILURE, 2019, 6 (06): : 1128 - 1139
  • [40] Bone Scintigraphy Imaging for Transthyretin Cardiac Amyloidosis
    Alexander, Kevin M.
    Witteles, Ronald M.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2020, 13 (06) : 1322 - 1324